24
FEATURE:
A
DEPARTMENTS
ART PAPPAS
6
8
10
Art Pappas, founder of Pappas Ventures and a
seasoned veteran of life science investment, is
bullish but highly selective in funding early-stage
companies and products.
14
16
20
50
52
September 2013
CONTENTS
Welcome to
Life Science Leader
56
60
64
30
36
42
68
AZ'S "WINNING WITH
SCIENCE" STRATEGY
ESTABLISHING
BRAND PROTECTION
CONTINUOUS
MANUFACTURING
70
Ron Guido addresses the issue of
counterfeit drugs and how to protect
your company.
How Pfizer is deploying continuous and
batch processes as a hybrid approach
to improving manufacturing efficiencies
An exclusive interview with Menelas
Pangalos, executive VP of innovative
medicines at AZ
BRAND
74
Editor's Note
Editorial Board/Ask The Board
Capitol Perspectives
Republicans And Health Policy
Companies To Watch
Esperion Therapeutics
Outsourcing Insights
Top CROs By Therapeutic Indication
Bio Innovation Notes
Innovation In Expressions Systems
Finance & Business Development
Importance of Investments
Finance & Business Development
When To Go Public
Information Technology
Cloud Computing
Pharma Business
Corporate Espionage
Global Business Update
China's Biopharma IP
Industry Leader
Choosing Outsourcing Models
Industry Leader
Risk And Package Quality
Leadership Lessons
"I Trust You" Style Of Mgt.
@RFWrightLSL
linkedin.com/in/robertfwright
pintrest.com/rfwrightlsl
facebook.com/LifeScienceLeader
4
LifeScienceLeader.com
September 2013